Divestiture • Life Science

bioMerieux Acquires PML Microbiologicals

On December 8, 2008, bioMerieux acquired life science company PML Microbiologicals from Pelican Life Sciences Group for 30M USD

Acquisition Context
  • This is bioMerieux’s 7th transaction in the Life Science sector.
  • This is bioMerieux’s 6th largest (disclosed) transaction.
  • This is bioMerieux’s 5th transaction in the United States.
  • This is bioMerieux’s 1st transaction in Oregon.

Explore All 789 Divestiture Life Science Deals - Search the Database Free


M&A Deal Summary

Date December 8, 2008
Target PML Microbiologicals
Sector Life Science
Buyer(s) bioMerieux
Sellers(s) Pelican Life Sciences Group
Deal Type Divestiture
Deal Value 30M USD

Target Company

PML Microbiologicals

Wilsonville, Oregon, United States
PML Microbiologicals, Inc. is a provider of culture media and microbiological products in North America for both clinical and industrial applications.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

bioMerieux

Marcy l'Etoile, France

Category Company
Founded 1963
Sector Life Science
Employees14,147
Revenue 4.0B EUR (2024)
DESCRIPTION

bioMerieux is a provider in the field of in vitro diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening, monitoring, and cardiovascular emergencies. bioMerieux was founded in 1963 and is based in Marcy-l'Étoile, France.


Deal Context for Buyer #
Overall 10 of 21
Sector: Life Science 7 of 11
Type: Divestiture 3 of 3
State: Oregon 1 of 1
Country: United States 5 of 8
Year: 2008 3 of 3
Size (of disclosed) 6 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-09-11 AviaraDX

San Diego, California, United States

AviaraDX, Inc. is a developing and commercializing molecular diagnostic technologies for personalized medicine in cancer treatment.

Buy $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-14 Meikang Biotech Co.

Shanghai, China

Meikang Biotech (Shanghai) Co., Ltd. is a manufacturer of rapid tests products.

Buy -

Seller Profile 1

SELLER

Pelican Life Sciences Group

San Diego, California, United States

Category Company
Sector Life Science
DESCRIPTION

Pelican Life Sciences Group is a provider of diagnostic solutions.


Deal Context for Seller #
Overall 1 of 1
Sector: Life Science 1 of 1
Type: Divestiture 1 of 1
State: Oregon 1 of 1
Country: United States 1 of 1
Year: 2008 1 of 1
Size (of disclosed) 1 of 1